Iran’s daily COVID-19 deaths reached the lowest number since April 1 during the 24-hour period to Saturday, standing at 108, announced the Health Ministry in a statement.
According to the statement, daily infections during the period amounted to 6,448.
The statement said the total COVID-19 death toll and infections since the outbreak in late February 2020 stand at 82,854 and 3,086,974, respectively.
It added that 3,307 COVID-19 patients are in critical condition, and of the newly-detected cases, 931 individuals have been hospitalized.
The ministry said 2,736,013 COVID-19 patients have so far either recovered from the disease or have been discharged from hospitals.
It also announced that 22,321,457 coronavirus diagnostic tests have so far been carried out, and 5,281,275 doses of COVID-19 vaccines have been administered to people.
The Health Ministry said 22 cities in the country are coded red (very high-risk), while 175 are in the orange zone (high-risk), noting that based on a decision by the National Task Force for Fighting the Coronavirus, travel to and from these cities is prohibited.
The number of the country’s yellow (medium-risk) and blue (low-risk) cities are 251 and zero, respectively, according to the ministry’s Monday statement.
Iran has been grappling with the fourth wave of COVID-19 infections over the past few weeks that has caused the country to see daily record-high deaths and infections of above 450 and 21,000 and impose a partial lockdown in very high-risk cities, closing certain businesses and public places.
Vaccination to gain momentum
The executive manager of the project to develop the Iranian COVID-19 vaccine, dubbed COVIran Barakat, said the ground has been prepared for accelerated public inoculation in the country following the issuance of the emergency use authorization for the jab, IRNA reported.
Reza Mazhari added from now on, the vaccine will be constantly provided to the Health Ministry for administration in different doses after being produced and quarantined for 14 days.
On Monday, Health Minister Saeed Namaki said the emergency use authorization for COVIran Barakat vaccine has been granted.
Developed by Iranian experts of the Execution of Imam Khomeini’s Order (EIKO), the jab is the first Iranian vaccine to receive approval for public use.
Mazhari added the first batch of the vaccine was delivered to the Health Ministry on June 16, saying the ministry has stationed its representative at the EIKO to receive the vaccine continuously.
He said weekly production of the vaccine will reach four million doses and seven million doses in August and September respectively.
Mazhari said in July, three million doses of the jab were produced.
The development of COVIran Barakat vaccine began in March 2020.